Viracta Therapeutics (VIRX) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.37
-0.32
-0.28
-0.23

Details

Expected EPS
-0.366667
Actual EPS
-0.25
Surprise EPS
0.12
Surprise Percent
+31.82%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.25 per share for Q3 2024.

0 Comments

Share your thoughts